Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1989;80:1159-1165

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ellis, S. G.
Right arrow Articles by Califf, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ellis, S. G.
Right arrow Articles by Califf, R. M.

Circulation, Vol 80, 1159-1165, Copyright © 1989 by American Heart Association


ARTICLES

Recurrent ischemia without warning. Analysis of risk factors for in- hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator

SG Ellis, EJ Topol, BS George, DJ Kereiakes, D Debowey, KN Sigmon, A Pickel, KL Lee and RM Califf
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109.

Ischemic events after successful thrombolysis have been reported to occur in 18-32% of patients treated for acute myocardial infarction with thrombolytic therapy, and previous studies in which patients received streptokinase suggest that risk of early recurrent ischemia is closely related to the presence of a high-grade residual stenosis. If these events are predictable after intravenous recombinant tissue- plasminogen activator (rt-PA) thrombolytic therapy, then further intervention after its use could be targeted at selected patients. One- hundred ninety-two patients from the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I and TAMI III trials had successful rt-PA- mediated thrombolysis without immediate coronary angioplasty (PTCA). One-hundred seventy-four of these patients (92%) had prehospital discharge angiography. The mean age was 56 +/- 11 years; 81% were men; the infarct-related artery was the left anterior descending in 76 (39.8%), the left circumflex in 24 (12.6%), and the right coronary artery in 91 (47.6%). Thrombolysis with rt-PA resulted in a residual 73 +/- 13% diameter and 0.95 +/- 0.51 mm stenosis by quantitative coronary arteriography, and Thrombolysis in Myocardial Infarction (TIMI) flow grade 2 in 59.2% and 3 in 40.8% of stenoses as assessed on angiograms obtained 90 minutes after the initiation of rt-PA therapy. Recurrent ischemic events (ischemia requiring emergency percutaneous transluminal coronary angioplasty or urgent bypass surgery, reocclusion of the infarct-related artery, or cardiac death) occurred in 41 patients (21.3%).(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
S. Rispler, Z. Keidar, E. Ghersin, A. Roguin, A. Soil, R. Dragu, D. Litmanovich, A. Frenkel, D. Aronson, A. Engel, et al.
Integrated Single-Photon Emission Computed Tomography and Computed Tomography Coronary Angiography for the Assessment of Hemodynamically Significant Coronary Artery Lesions
J. Am. Coll. Cardiol., March 13, 2007; 49(10): 1059 - 1067.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Namdar, T. F. Hany, P. Koepfli, P. T. Siegrist, C. Burger, C. A. Wyss, T. F. Luscher, G. K. von Schulthess, and P. A. Kaufmann
Integrated PET/CT for the Assessment of Coronary Artery Disease: A Feasibility Study
J. Nucl. Med., June 1, 2005; 46(6): 930 - 935.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Sakamoto, H. Ogawa, K. Takazoe, M. Yoshimura, H. Shimomura, Y. Moriyama, H. Arai, and K. Okajima
Effect of activated protein C on plasma plasminogen activator inhibitor activity in patients with acute myocardial infarction treated with alteplase: Comparison with unfractionated heparin
J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1389 - 1394.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K.-H. Mak and E. J. Topol
Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus
J. Am. Coll. Cardiol., March 1, 2000; 35(3): 563 - 568.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Van Belle, J.-M. Lablanche, C. Bauters, N. Renaud, E. P. McFadden, and M. E. Bertrand
Coronary Angioscopic Findings in the Infarct-Related Vessel Within 1 Month of Acute Myocardial Infarction : Natural History and the Effect of Thrombolysis
Circulation, January 13, 1998; 97(1): 26 - 33.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. J. Topol and S. E. Nissen
Our Preoccupation With Coronary Luminology : The Dissociation Between Clinical and Angiographic Findings in Ischemic Heart Disease
Circulation, October 15, 1995; 92(8): 2333 - 2342.
[Abstract] [Full Text]


Home page
ANN INTERN MEDHome page
R. J. Krone
The Role of Risk Stratification in the Early Management of a Myocardial Infarction
Ann Intern Med, February 1, 1992; 116(3): 223 - 237.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
J. J. Popma and E. J. Topol
Adjuncts to Thrombolysis for Myocardial Reperfusion
Ann Intern Med, July 1, 1991; 115(1): 34 - 44.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
E. J. Topol, D. R. Holmes, and W. J. Rogers
Coronary Angiography after Thrombolytic Therapy for Acute Myocardial Infarction
Ann Intern Med, May 15, 1991; 114(10): 877 - 885.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
A. Jain, G. Hunter Myers, M. W. Rowe, G. J. Dehmer, and D. S. Robinson
Comparison of Coronary Angiographic Features and Oral Dipyridamole Thallium 201 Tomography
Angiology, February 1, 1991; 42(2): 99 - 105.
[Abstract] [PDF]